Pathological complete response to FLOT chemotherapy with/without durvalumab in resectable gastric and gastroesophageal junction cancer:subgroup analysis by region from the phase 3, randomized, double-blind MATTERHORN study

Yelena Y. Janjigian, Salah-Eddin Al-Batran, Zen A. Wainberg, Eric Van Cutsem, Daniela Molena, Kei Muro, Woo Jin Hyung, Lucjan Wyrwicz, Do-Youn Oh, Takeshi Omori, Markus Moehler, Marcelo Garrido, Sulene C. S. Oliveira, Moishe Liberman, Victor C. Oliden, Mehmet Bilici, John Kurland, Ioannis Xynos, Helan Mann, Josep Tabernero

@inproceedings{janjigian2024-228453,
  author = {Janjigian, Yelena Y. and Al-Batran, Salah-Eddin and Wainberg, Zen A. and Van Cutsem, Eric and Molena, Daniela and Muro, Kei and Hyung, Woo Jin and Wyrwicz, Lucjan and Oh, Do-Youn and Omori, Takeshi and Moehler, Markus and Garrido, Marcelo and Oliveira, Sulene C. S. and Liberman, Moishe and Oliden, Victor C. and Bilici, Mehmet and Kurland, John and Xynos, Ioannis and Mann, Helan and Tabernero, Josep},
  title = {Pathological complete response to FLOT chemotherapy with/without durvalumab in resectable gastric and gastroesophageal junction cancer:subgroup analysis by region from the phase 3, randomized, double-blind MATTERHORN study},
  booktitle = {Annual Meeting of the Society-of-Surgical-Oncology (SSO)},
  address = {Georgia},
  year = {2024},
  url = {https://akademik.atauni.edu.tr/yayinlar/228453-pathological-complete-response-to-flot-chemotherapy-withwithout-durvalumab-in}
}